Increased 18F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): A prospective pilot study

被引:58
作者
De Ruysscher, Dirk [1 ]
Houben, Ans
Aerts, Hugo J. W. L.
Dehing, Cary
Wanders, Rinus
Ollers, Michel
Dingemans, Anne-Marie C. [2 ]
Hochstenbag, Monique [2 ]
Boersma, Liesbeth
Borger, Jacques
Dekker, Andre
Lambin, Philippe
机构
[1] Maastricht Univ, Med Ctr, Dept Radiat Oncol, Maastro Clin,GROW Res Inst, NL-6229 ET Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, Dept Lung Dis, NL-6229 ET Maastricht, Netherlands
关键词
RILT; Radiopneumonitis; NSCLC; Radiotherapy; Lung; Toxicity; 3-DIMENSIONAL CONFORMAL RADIOTHERAPY; HYPERFRACTIONATED ACCELERATED RADIOTHERAPY; VOLUME HISTOGRAM ANALYSIS; I DOSE-ESCALATION; CANCER PATIENTS; PHASE-I/II; NEOADJUVANT CHEMOTHERAPY; CONCURRENT CHEMOTHERAPY; CELL; PNEUMONITIS;
D O I
10.1016/j.radonc.2009.01.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: As Radiation-Induced Lung Toxicity (RILT) is dose-limiting for radiotherapy (RT) of lung cancer and current parameters are only moderately associated with RILT, we sought for novel parameters associated with RILT. Patients and methods: In this prospective study, FDG-PET-CT scans were taken on days 0, 7 and 14 after initiation of high-dose RT in 18 patients with stage III non-small cell lung cancer. The maximal Standardized Uptake Value (SUV(max)) in the lung Outside of the GTV was used as a measure of FDG uptake. At the same time-points, the serum IL-6 concentrations were measured. RILT was defined as dyspned score >= 2 (CTCAE3.0). Results: Six of 18 patients developed RILT. Before RT, SUV(max) in the lung was not significantly different between patients who developed RILT and those who did not develop RILT. Patients who developed RILT post-radiation had a significant increased SUV on days 7 and 14 during RT, whereas the group that did not experience RILT showed no significant SUV changes. The SUV(max) of the lungs increased significantly more in the group that later developed RILT compared to those who did not develop RILT. Neither the IL-6 concentration nor the mean lung dose was associated with RILT. Conclusions: The increase in FDG uptake in the normal lung early during RT was highly associated with the subsequent development of clinical RILT. This may help to identify patients at high risk for RILT at a time when adjustments of the treatment or strategies to prevent RILT are still possible. (C) 2009 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 91 (2009) 415-420
引用
收藏
页码:415 / 420
页数:6
相关论文
共 40 条
[1]  
[Anonymous], 1993, J ICRU
[2]   Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis [J].
Arpin, D ;
Perol, D ;
Blay, JY ;
Falchero, L ;
Claude, L ;
Vuillermoz-Blas, S ;
Martel-Lafay, I ;
Ginestet, C ;
Alberti, L ;
Nosov, D ;
Etienne-Mastroianni, B ;
Cottin, V ;
Perol, M ;
Guerin, JC ;
Cordier, JF ;
Carrie, C .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8748-8756
[3]   Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy [J].
Belderbos, Jose S. A. ;
Heemsbergen, Wilma D. ;
De Jaeger, Katrien ;
Baas, Paul ;
Lebesque, Joos V. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (01) :126-134
[4]   Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma [J].
Bradley, J ;
Graham, MV ;
Winter, K ;
Purdy, JA ;
Komaki, R ;
Roa, WH ;
Ryu, JK ;
Bosch, W ;
Emami, B .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (02) :318-328
[5]   Tobacco smoking inhibits expression of proinflammatory Cytokines and activation of IL-1R-Associated kinase, p38, and NF-κB in alveolar macrophages stimulated with TLR2 and TLR4 Agonists [J].
Chen, Haiyan ;
Cowan, Mark J. ;
Hasday, Jeffrey D. ;
Vogel, Stefanie N. ;
Medvedev, Andrei E. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (09) :6097-6106
[6]   A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer:: clinical and dosimetric factors analysis [J].
Claude, L ;
Pérol, D ;
Ginestet, C ;
Falchero, L ;
Arpin, D ;
Vincent, M ;
Martel, I ;
Hominal, S ;
Cordier, JF ;
Carrie, C .
RADIOTHERAPY AND ONCOLOGY, 2004, 71 (02) :175-181
[7]   Significance of plasma transforming growth factor-β levels in radiotherapy for non-small-cell lung cancer [J].
De Jaeger, K ;
Seppenwoolde, Y ;
Kampinga, HH ;
Boersma, LJ ;
Belderbos, JSA ;
Lebesque, JV .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (05) :1378-1387
[8]   Hi-chart: A phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer [J].
De Ruysscher, Dirk ;
Wanders, Rinus ;
Van Haren, Erik ;
Hochstenbag, Monique ;
Geraedts, Wiel ;
Pitz, Cordula ;
Simons, Jean ;
Boersma, Liesbeth ;
Verschueren, Tom ;
Minken, Andre ;
Bentzen, Soren M. ;
Lambin, Philippe .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (01) :132-138
[9]   Pravastatin limits endothelial activation after irradiation and decreases the resulting inflammatory and thrombotic responses [J].
Gaugler, MH ;
Vereycken-Holler, V ;
Squiban, C ;
Vandamme, M ;
Vozenin-Brotons, MC ;
Benderitter, M .
RADIATION RESEARCH, 2005, 163 (05) :479-487
[10]   Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) [J].
Graham, MV ;
Purdy, JA ;
Emami, B ;
Harms, W ;
Bosch, W ;
Lockett, MA ;
Perez, CA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (02) :323-329